Everence Capital Management’s Cytokinetics CYTK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-13,510
| Closed | -$1.13M | – | 763 |
|
|
2023
Q4 | $1.13M | Hold |
13,510
| – | – | 0.08% | 206 |
|
|
2023
Q3 | $398 | Sell |
13,510
-2,940
| -18% | -$87 | 0.03% | 454 |
|
|
2023
Q2 | $620K | Hold |
16,450
| – | – | 0.05% | 304 |
|
|
2023
Q1 | $579 | Hold |
16,450
| – | – | 0.05% | 326 |
|
|
2022
Q4 | $754 | Hold |
16,450
| – | – | 0.07% | 259 |
|
|
2022
Q3 | $797K | Hold |
16,450
| – | – | 0.07% | 233 |
|
|
2022
Q2 | $646K | Buy |
16,450
+2,550
| +18% | +$100K | 0.06% | 264 |
|
|
2022
Q1 | $512K | Hold |
13,900
| – | – | 0.04% | 385 |
|
|
2021
Q4 | $634K | Hold |
13,900
| – | – | 0.05% | 338 |
|
|
2021
Q3 | $497K | Buy |
13,900
+3,700
| +36% | +$132K | 0.04% | 405 |
|
|
2021
Q2 | $202K | Hold |
10,200
| – | – | 0.02% | 699 |
|
|
2021
Q1 | $237K | Sell |
10,200
-4,710
| -32% | -$109K | 0.02% | 637 |
|
|
2020
Q4 | $310K | Hold |
14,910
| – | – | 0.03% | 504 |
|
|
2020
Q3 | $323K | Sell |
14,910
-1,470
| -9% | -$31.8K | 0.04% | 436 |
|
|
2020
Q2 | $339K | Hold |
16,380
| – | – | 0.04% | 417 |
|
|
2020
Q1 | $193K | Hold |
16,380
| – | – | 0.03% | 522 |
|
|
2019
Q4 | $174K | Hold |
16,380
| – | – | 0.03% | 633 |
|
|
2019
Q3 | $186K | Hold |
16,380
| – | – | 0.03% | 584 |
|
|
2019
Q2 | $184K | Hold |
16,380
| – | – | 0.03% | 585 |
|
|
2019
Q1 | $133K | Buy |
+16,380
| New | +$133K | 0.02% | 602 |
|